Alethia Young

Alethia Young is a seasoned finance professional with extensive experience in the biotech sector. Currently serving as Chief Financial Officer at Bicycle Therapeutics since July 2023, Alethia also holds board member positions at Pacira BioSciences, Inc. and PTC Therapeutics, Inc. Notable past roles include Chief Financial Officer at Graphite Bio and leading healthcare research at Cantor Fitzgerald. Alethia's career began in investment banking and equity research, working at JPMorgan and Deutsche Bank, with a strong focus on healthcare services and biotechnology. Academic credentials include a B.A. in Economics from Duke University.